PROMETIC PHARMA SMT LTD has a total of 101 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2002. It filed its patents most often in Mexico, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are LIMINAL BIOSCIENCES LTD, HOLMEIDE ANNE KRISTIN and GARBIL PHARMA INVESTIGACION CH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Mexico | 12 | |
#2 | Australia | 11 | |
#3 | EPO (European Patent Office) | 10 | |
#4 | Republic of Korea | 9 | |
#5 | United States | 8 | |
#6 | Israel | 7 | |
#7 | Brazil | 5 | |
#8 | Hong Kong | 5 | |
#9 | Philippines | 5 | |
#10 | Singapore | 5 | |
#11 | EAPO (Eurasian Patent Organization) | 4 | |
#12 | Taiwan | 4 | |
#13 | South Africa | 3 | |
#14 | China | 2 | |
#15 | Japan | 2 | |
#16 | Malaysia | 2 | |
#17 | Russian Federation | 2 | |
#18 | Bulgaria | 1 | |
#19 | Hungary | 1 | |
#20 | Norway | 1 | |
#21 | New Zealand | 1 | |
#22 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology | |
#5 | Basic materials chemistry | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Gagnon Lyne | 69 |
#2 | Grouix Brigitte | 46 |
#3 | Laurin Pierre | 42 |
#4 | Zacharie Boulos | 39 |
#5 | Penney Christopher | 33 |
#6 | Geerts Lilianne | 18 |
#7 | Lyne Gagnon | 15 |
#8 | Abbott Shaun | 12 |
#9 | Brigitte Grouix | 11 |
#10 | Leduc Martin | 7 |
Publication | Filing date | Title |
---|---|---|
KR20170066614A | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes | |
CN106999459A | Phenyl ketone carboxylate compounds and pharmaceutical composition for preventing and treating osteoporosis | |
TW201343160A | Method for the preparation of triglycerides of medium-chain length fatty acids | |
EP2632885A1 | Phenylketone carboxylate compounds and pharmaceutical uses thereof | |
MY162420A | Compounds and compositions for the treatment of cancer | |
MX2010004856A | Medium-chain length fatty acids and glycerides as nephroprotection agents. | |
AU2004291186A1 | Triazine dimers for the treatment of autoimmune diseases |